These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. Siegert W; Beyer J; Strohscheer I; Baurmann H; Oettle H; Zingsem J; Zimmermann R; Bokemeyer C; Schmoll HJ; Huhn D J Clin Oncol; 1994 Jun; 12(6):1223-31. PubMed ID: 7911158 [TBL] [Abstract][Full Text] [Related]
10. [Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin]. Ribrag V; Droz JP; Bouleuc C; Theodore C; Ghosn M; Pico JL; Azab M; Ostronoff M; Hayat M Presse Med; 1990 Jul 7-14; 19(27):1263-6. PubMed ID: 2143824 [TBL] [Abstract][Full Text] [Related]
11. Results of postchemotherapy adjunctive retroperitoneal lymph node dissection in non-seminomatous germ cell cancer patients. Goepel M; Recker F; Otto T; Krege S; Rübben H Urol Int; 1996; 57(4):209-12. PubMed ID: 8961487 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C; J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987 [TBL] [Abstract][Full Text] [Related]
13. [Antineoplastic chemotherapy in the therapeutic plan of germinal testicular neoplasms]. Vogler H; Schönberger B Z Urol Nephrol; 1982 May; 75(5):307-13. PubMed ID: 7113486 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors]. Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998 [TBL] [Abstract][Full Text] [Related]
15. [Chemotherapeutic intensification in germ cell tumors]. Droz JP; Pico JL; Ghosn M; Ostronoff M; Azab M; Theodore C; Hayat M Bull Cancer; 1990; 77(4):349-54. PubMed ID: 2354250 [TBL] [Abstract][Full Text] [Related]
16. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059 [TBL] [Abstract][Full Text] [Related]
17. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors]. Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774 [TBL] [Abstract][Full Text] [Related]
18. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)]. Nicolai N; Necchi A; Piva L; Stagni S; Catanzaro MA; Biasoni D; Milani A; Torelli T; Salvioni R Urologia; 2010; 77(2):84-7. PubMed ID: 20890864 [TBL] [Abstract][Full Text] [Related]
19. Rates of death from testicular cancer in Ontario in 1964-82: analysis by major histologic subgroups. Marrett LD; Weir HK; Clarke EA; Magee CJ CMAJ; 1986 Nov; 135(9):999-1002. PubMed ID: 3019502 [TBL] [Abstract][Full Text] [Related]
20. The role of ifosfamide in testicular cancer. Schmoll HJ Semin Oncol; 1989 Feb; 16(1 Suppl 3):82-95. PubMed ID: 2649987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]